Commodore Capital LP Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$431.8B
Holdings
25
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (25 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | OPHTEURIVERIC BIO INC | 3,217,163 | $53.8B | 12.46% | |
| 2 | MRUSMERUS N V | 1,498,890 | $47.7B | 11.04% | |
| 3 | ACRSACLARIS THERAPEUTICS INC | 2,672,346 | $38.9B | 9.00% | |
| 4 | XENEXENON PHARMACEUTICALS INC | 1,090,126 | $34.1B | 7.89% | |
| 5 | CYTKCYTOKINETICS INC | 704,537 | $32.1B | 7.44% | |
| 6 | PTGXPROTAGONIST THERAPEUTICS INC | 805,573 | $27.6B | 6.38% | |
| 7 | BLUBELLUS HEALTH INC NEW | 3,124,613 | $25.2B | 5.83% | |
| 8 | COGTCOGENT BIOSCIENCES INC | 2,281,315 | $19.6B | 4.53% | |
| 9 | CBAYUSDCYMABAY THERAPEUTICS INC | 5,419,896 | $18.3B | 4.24% | |
| 10 | VRDNVIRIDIAN THERAPEUTICS INC | 847,683 | $16.8B | 3.88% | |
| 11 | —SATSUMA PHARMACEUTICALS INC | 3,711,286 | $16.7B | 3.87% | |
| 12 | VTGNUSDVISTAGEN THERAPEUTICS INC | 8,464,999 | $16.5B | 3.82% | |
| 13 | CCCCC4 THERAPEUTICS INC | 481,094 | $15.5B | 3.59% | |
| 14 | CELCCELCUITY INC | 920,464 | $12.1B | 2.81% | |
| 15 | 1T7TRICIDA INC | 1,247,043 | $11.9B | 2.76% | |
| 16 | TNYATENAYA THERAPEUTICS INC | 513,930 | $9.7B | 2.26% | |
| 17 | ALLKGUSDALLAKOS INC | 815,667 | $8.0B | 1.85% | |
| 18 | KALVKALVISTA PHARMACEUTICALS INC | 312,553 | $4.1B | 0.96% | |
| 19 | KRON1USDKRONOS BIO INC | 298,839 | $4.1B | 0.94% | |
| 20 | DYNDYNE THERAPEUTICS INC | 305,125 | $3.6B | 0.84% | |
| 21 | IVAINVENTIVA SA | 262,658 | $3.6B | 0.83% | |
| 22 | GNCAQGENOCEA BIOSCIENCES INC | 3,079,756 | $3.6B | 0.83% | |
| 23 | MREOMEREO BIOPHARMA GROUP PLC | 1,954,970 | $3.1B | 0.72% | |
| 24 | PMVPPMV PHARMACEUTICALS INC | 125,000 | $2.9B | 0.67% | |
| 25 | —BCLS ACQUISITION CORP | 250,000 | $2.5B | 0.57% |